The BCL2 antagonist ABT-199 triggers apoptosis, and augments ibrutinib and idelalisib mediated cytotoxicity in CXCR4 Wild-type and CXCR4 WHIM mutated Waldenstrom macroglobulinaemia cells

Br J Haematol. 2015 Jul;170(1):134-8. doi: 10.1111/bjh.13278. Epub 2015 Jan 12.
No abstract available

Keywords: ABT-199; BCL2; CXCR4; Ibrutinib; Waldenström macroglobulinemia.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / analogs & derivatives
  • Antineoplastic Combined Chemotherapy Protocols / pharmacology*
  • Apoptosis / drug effects
  • Apoptosis Regulatory Proteins / genetics*
  • Apoptosis Regulatory Proteins / metabolism
  • Bcl-2-Like Protein 11
  • Bridged Bicyclo Compounds, Heterocyclic / administration & dosage
  • Bridged Bicyclo Compounds, Heterocyclic / pharmacology*
  • Drug Synergism
  • Humans
  • Membrane Proteins / genetics*
  • Membrane Proteins / metabolism
  • Piperidines
  • Proto-Oncogene Proteins / genetics*
  • Proto-Oncogene Proteins / metabolism
  • Purines / administration & dosage
  • Purines / pharmacology*
  • Pyrazoles / administration & dosage
  • Pyrazoles / pharmacology*
  • Pyrimidines / administration & dosage
  • Pyrimidines / pharmacology*
  • Quinazolinones / administration & dosage
  • Quinazolinones / pharmacology*
  • Receptors, CXCR4 / genetics*
  • Receptors, CXCR4 / metabolism
  • Sulfonamides / administration & dosage
  • Sulfonamides / pharmacology*
  • Waldenstrom Macroglobulinemia / drug therapy*
  • Waldenstrom Macroglobulinemia / genetics
  • Waldenstrom Macroglobulinemia / metabolism
  • Waldenstrom Macroglobulinemia / pathology

Substances

  • Apoptosis Regulatory Proteins
  • BCL2L11 protein, human
  • Bcl-2-Like Protein 11
  • Bridged Bicyclo Compounds, Heterocyclic
  • CXCR4 protein, human
  • Membrane Proteins
  • Piperidines
  • Proto-Oncogene Proteins
  • Purines
  • Pyrazoles
  • Pyrimidines
  • Quinazolinones
  • Receptors, CXCR4
  • Sulfonamides
  • ibrutinib
  • Adenine
  • venetoclax
  • idelalisib